Concepedia
Statistics
Publications
8
Citations
333
H-Index
Active since
2002
Affiliations
Emory University(Current)
Clemson University
Children's Healthcare of Atlanta
Prisma Health
Rady Children's Hospital-San Diego
Susan K. Peirce is an author at Emory University specializing in cancer cell signaling, oncology, and signal transduction.
Publications per year
2002–2015
Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma
Kelly C. Goldsmith, Michelle Gross, Susan K. Peirce et al. · Cancer Research · 2012 · 79 citations
Life Sciences, Cancer Biology, Oncology +17
The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.
Susan K. Peirce, Harry W. Findley · PubMed · 2009 · 62 citations
Medicine, Oncology, Pharmacology +16
Regulation of bcl-2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R
Michael T. Beck, Susan K. Peirce, Wen Y. Chen · Oncogene · 2002 · 49 citations
Life Sciences, Molecular Biology, Pharmacology +11
Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice
Susan K. Peirce, Wen Y. Chen · Oncogene · 2003 · 48 citations
Life Sciences, Endocrinology, Molecular Biology +11
The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention
Susan K. Peirce, Harry W. Findley, Chengyu Prince et al. · Cancer Chemotherapy and Pharmacology · 2010 · 38 citations · Full text
1–5 of 8